The results showed that BAMBI was positively correlated with tumor proliferation, EMT markers, MYC targets, and cellular response to hypoxia in HCC; it was negatively correlated with glycolysis/gluconeogenesis and fatty acid degradation pathways. This evidence concerns the gene BAMBI and hepatocellular carcinoma.